Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
3
×
fda
life sciences
national blog main
san francisco blog main
boston blog main
boston top stories
cancer immunotherapy
national top stories
new york blog main
san francisco top stories
acute myeloid leukemia
alx oncology
autoimmune diseases
berkeley lights
biotech ipos
boston
cancer
cancer drugs
cd47
center for medicare and medicaid services
chronic kidney disease
clinical trials
companion diagnostic
daniel o'day
deerfield healthcare technology acquisitions
deerfield management company
europe blog main
europe top stories
food and drug administration
foundation medicine
foundationone cdx
foundationone heme
genentech
immunotherapy
investing
kidney disease
medical device
medicare
What
momentum
3
×
acquire
agreed
arrival
big
billion
biotech
broad
building
companies
confidence
days
deal
developer
didn’t
disease
drug
established
firm
foundation
gain
genentech
hasn’t
industry
ipo
ipos
life
lung
market
medicine
morning
new
pah
panels
pay
pays
picked
profiling
raised
rare
Language
unset
Current search:
momentum
×
deals
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
